NCT01566812 Effect of Breastfeeding Optimization on Early Vascular Development Status UNKNOWN Phase NA
NCT01557855 Investigation of a Novel Gene Expression Test (ASGES or Corus CAD) for Diagnosis of Obstructive Coronary Artery Disease Status COMPLETED Phase N/A
NCT01544829 The Acute Effect of 2 Different Serving Regimens of Theobromine on Physiological Effects Status COMPLETED Phase NA
NCT01533857 Pharmacokinetic Behavior of Phenolic Acids Derived From Black Tea Status COMPLETED Phase NA
NCT01526811 Endurant™ Stent Graft System in the Treatment of Infra-renal Abdominal Aortic Aneurysms (ENDURANT France) Status COMPLETED Phase N/A
NCT01517542 Evaluation of Effectiveness of Nutritional Counseling in Patients After Stroke Status WITHDRAWN Phase NA
NCT01515878 Hemocontrol's Effectiveness on the Reduction of Cardiovascular Long-term EventS Status UNKNOWN Phase PHASE4
NCT01510223 The Effect of Macronutrients in the Diet on Digestive and Cardiovascular Health Status COMPLETED Phase NA
NCT01492361 A Study of AMR101 to Evaluate Its Ability to Reduce Cardiovascular Events in High-Risk Patients With Hypertriglyceridemia and on Statin Status COMPLETED Phase PHASE3
NCT01490333 Sunweavers: Supporting Native American Women's Vitamin D Research Status COMPLETED Phase PHASE2
NCT01486030 Effect of Exercise Stress Testing on Peripheral Gene Expression Using Corus CAD (or ASGES) Diagnostic Test Status COMPLETED Phase N/A
NCT01481389 The Effect of Theobromine on Blood Lipid Parameters in Healthy Subjects Status COMPLETED Phase NA
NCT01475682 Long Term Cardiovascular Complications in Men With Obstructive Sleep Apnea Status UNKNOWN Phase N/A
NCT01474161 Comparative Bioavailability - Gender Effect - Single and Multiple Ascending Dose Safety and Pharmacokinetic Study of GFT505 Status COMPLETED Phase PHASE1
NCT01471522 International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA) Status COMPLETED Phase NA
NCT01464476 Efficacy and Safety Study of Azimilide on the Incidence of Cardiovascular Hospitalizations/Emergency Department Visits or Cardiovascular Death in Patients With an Implantable Cardioverter Defibrillator (ICD) (SHIELD-2) Status TERMINATED Phase PHASE3